Advances in Human Immune System Mouse Models for Personalized Treg-Based Immunotherapies

Area of Science:

• Immunology
• Stem Cell Biology
• Cancer Research
• Personalized Medicine

Background:

• Human immune system (HIS) mice are crucial for personalized medicine and immune-based therapy translation.
• Existing HIS mouse models face limitations like Graft-vs.-host disease and low engraftment efficacy.
• Patient-derived induced pluripotent stem cells (iPSCs) offer a promising alternative for creating advanced HIS models.

Purpose of the Study:

• To review advances in personalized HIS models utilizing reprogrammed iPSCs.
• To discuss the application of HIS mice in studying human regulatory T cells (Tregs) in vivo.
• To explore requirements for efficient Treg targeting in personalized cancer immunotherapies.

Main Methods:

• Review of current literature on HIS mice models and iPSC reprogramming techniques.
• Analysis of studies investigating immune activation, regulation, and disease modeling in HIS mice.
• Examination of research focusing on regulatory T cells (Tregs) within HIS mouse models.

Main Results:

• Recent advances in reprogramming iPSCs into hematopoietic stem cells (HSCs) overcome limitations of traditional HIS models.
• Personalized HIS mice facilitate bridging preclinical research with human diseases.
• HIS mice provide a platform for studying human Tregs in vivo, crucial for understanding tumor immune evasion.

Conclusions:

• Personalized HIS mice models, particularly those derived from iPSCs, are vital for advancing cancer immunotherapy.
• These models enable in-depth study of regulatory T cells (Tregs) and their role in tumor immunity.
• Further research using these models will refine strategies for effective Treg-targeting in personalized cancer therapies.